CSP
1 min read
11

#24-427 Delisting of Derivatives from NGM

December 11, 2024
0

Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
2 min read
9

Insider information, profit warning: Wetteri Plc lowers its financial guidance for the current year

December 11, 2024
0

Reading Time: 2 minutes Wetteri Plc Insider Information 11 December 2024 at 20.30 Wetteri Plc is lowering its financial guidance for 2024 as the company’s October results fell short of expectations. Additionally, the company anticipates that the November and December results will be lower than

Continue Reading
CSP
1 min read
28

ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 11.12.2024

December 11, 2024
0

Reading Time: < 1 minute   ALEXANDRIA GROUP OYJ NOTIFICATION     11.12.2024 at 18:30 EET   ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 11.12.2024   Date 11.12.2024   Exchange transaction Buy   Share class ALEX   Amount 250   Average price/share 8.7500 EUR Highest

Continue Reading
CSP
1 min read
28

Fondia Plc: Share repurchase 11.12.2024

December 11, 2024
0

Reading Time: < 1 minute Fondia Plc Company release 11.12.2024 at 6.45 p.m. EET   Fondia – Acquisition of own shares 11.12.2024   Fondia Plc   First North Finland   Date 11.12.2024 Exchange transactions Buy Share class FONDIA Amount, shares 704 Average price/share, EUR 4,881250

Continue Reading
CSP
1 min read
28

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 11.12.2024

December 11, 2024
0

Reading Time: < 1 minute Stock Exchange Release 11.12.2024 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 11.12.2024   Date 11.12.2024   Exchange transaction Buy   Share class FSKRS   Amount  2,000   Average price/share 14.2200 EUR Highest price/share 14.2200 EUR Lowest price/share

Continue Reading
IISc and Ittiam Systems to Collaborate at the Frontiers of AI Research
BWI
4 min read
31

IISc and Ittiam Systems to Collaborate at the Frontiers of AI Research

December 11, 2024
0

Reading Time: 3 minutes   Bengaluru, Karnataka, India:  Ittiam Systems today announced that it has signed a three-year agreement with Indian Institute of Science (IISc) to extend its ongoing CSR partnership to exciting new areas at the cutting edge of Artificial Intelligence research and IISc’s flagship

Continue Reading
CSP
1 min read
25

Bluestep Bank Lowers Mortgage Rates

December 11, 2024
0

Reading Time: < 1 minute Bluestep Bank, a part of Enity Bank Group AB (publ), is lowering the interest rates for mortgages for interest periods of 3 months, 1 year, 3 years and 5 years. The table below shows the changes to Bluestep Bank’s mortgage

Continue Reading
SGT University Closes the Year with a Series of Landmark Achievements
NV
5 min read
31

SGT University Closes the Year with a Series of Landmark Achievements

December 11, 2024
0

Reading Time: 3 minutes In a landmark development for the field of special education, SGT University, a prominent educational institution in the Delhi NCR region, has inaugurated UDAAN, a pioneering “School of Experiential Learning” for children with diverse learning needs. This special centre is set to redefine the landscape

Continue Reading
CSP
3 min read
32

Publication of a Prospectus – Royal Bank of Canada

December 11, 2024
0

Reading Time: 2 minutes Regulatory Announcement Royal Bank of CanadaDecember 11, 2024 Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. The following prospectus has been approved by the Financial Conduct Listing Authority is available for

Continue Reading
Orthogon Therapeutics Closes Oversubscribed .2M Financing to Advance First Oral Therapy for BK Polyomavirus
BWI
4 min read
26

Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus

December 11, 2024
0

Reading Time: 3 minutes Canton, Mass., United States:   Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing round, exceeding its $5M target and bringing total funding to over $25M. This funding will accelerate the development of its first-in-class

Continue Reading